a developer of pharmaceutical products
Industry Biotechnology
A.I.dvisor tells us that CRVO and XLO have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRVO and XLO's prices will move in lockstep.
Ticker / NAME | Correlation To CRVO | 1D Price Change % | ||
---|---|---|---|---|
CRVO | 100% | -12.89% | ||
XLO - CRVO | 21% Poorly correlated | -13.63% | ||
KRRO - CRVO | 21% Poorly correlated | -7.02% | ||
APM - CRVO | 21% Poorly correlated | +1.34% | ||
TRML - CRVO | 20% Poorly correlated | -4.57% | ||
ANAB - CRVO | 9% Poorly correlated | -5.28% | ||
More |
Ticker / NAME | Correlation To CRVO | 1D Price Change % |
---|---|---|
CRVO | 100% | -12.89% |
pharmaceuticals theme (167 stocks) | 9% Poorly correlated | +0.82% |
drugs theme (265 stocks) | 4% Poorly correlated | +5.37% |
biotechnology theme (248 stocks) | 3% Poorly correlated | +5.56% |